Related references
Note: Only part of the references are listed.Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
David Adams et al.
LANCET NEUROLOGY (2021)
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study (vol 20, pg 49, 2021)
D. Adams et al.
LANCET NEUROLOGY (2021)
Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure-Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis
Xiaoping Zhang et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
Laura Obici et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2020)
TTR gene silencing therapy in post liver transplant hereditary ATTR amyloidosis patients
Orly Moshe-Lilie et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2020)
A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis
Teresa Coelho et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Patient-reported outcomes on familial amyloid polyneuropathy (FAP)
Fabian J. Bolte et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease
David Adams et al.
NATURE REVIEWS NEUROLOGY (2019)
Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS+7
P. James B. Dyck et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
M. D. Benson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathy
Vincent Algalarrondo et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2018)
Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy
Teresa Coelho et al.
NEUROLOGY (2018)
Tafamidis for a Transplant Patient with Transthyretin Amyloid Polyneuropathy
Jesus Romero-Imbroda et al.
JOURNAL OF CLINICAL NEUROLOGY (2017)
One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition
O. B. Suhr et al.
JOURNAL OF INTERNAL MEDICINE (2017)
Red-flag symptom clusters in transthyretin familial amyloid polyneuropathy
Isabel Conceicao et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2016)
Hereditary ATTR amyloidosis: a single-institution experience with 266 patients
Paul L. Swiecicki et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2015)
Evolving landscape in the management of transthyretin amyloidosis
Philip N. Hawkins et al.
ANNALS OF MEDICINE (2015)
Liver Transplantation in Transthyretin Amyloidosis: Issues and Challenges
Andreia Carvalho et al.
LIVER TRANSPLANTATION (2015)
Rapid progression of familial amyloidotic polyneuropathy A multinational natural history study
David Adams et al.
NEUROLOGY (2015)
Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
Bo-Goran Ericzon et al.
TRANSPLANTATION (2015)
Prediction of Long-Term Survival After Liver Transplantation for Familial Transthyretin Amyloidosis
Vincent Algalarrondo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy
Etta J. Vinik et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2014)
THAOS: Gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease
Jonas Wixner et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Cardiac amyloidosis: Updates in diagnosis and management
Dania Mohty et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2013)
THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis
Teresa Coelho et al.
CURRENT MEDICAL RESEARCH AND OPINION (2013)
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective
Claudio Rapezzi et al.
EUROPEAN HEART JOURNAL (2013)
Guideline of transthyretin-related hereditary amyloidosis for clinicians
Yukio Ando et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant
Prayman T. Sattianayagam et al.
EUROPEAN HEART JOURNAL (2012)
Amyloid Neuropathies
Susan C. Shin et al.
MOUNT SINAI JOURNAL OF MEDICINE (2012)
COMPASS 31: A Refined and Abbreviated Composite Autonomic Symptom Score
David M. Sletten et al.
MAYO CLINIC PROCEEDINGS (2012)
Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies
S. I. van Nes et al.
NEUROLOGY (2011)
Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30)
Gösta Holmgren et al.
CLINICAL GENETICS (2010)
Comparison of outcome data after liver transplant: Familial amyloid polyneuropathy (Portuguese type) recipients versus classical indications for liver transplant
Sá P. Couto et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2010)
Liver Transplantation and Combined Liver-Heart Transplantation in Patients with Familial Amyloid Polyneuropathy: A Single-Center Experience
Ana-Paula Barreiros et al.
LIVER TRANSPLANTATION (2010)
Progression of transthyretin amyloid neuropathy after liver transplantation
Juris J. Liepnieks et al.
NEUROLOGY (2010)
Quality of life in patients with familial amyloidotic polyneuropathy long-term after liver transplantation
Gerda Drent et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2009)
Liver Transplantation for Familial Amyloidotic Polyneuropathy: Impact on Swedish Patients' Survival
Sadahisa Okamoto et al.
LIVER TRANSPLANTATION (2009)
Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials
Craig H. Mallinckrodt et al.
DRUG INFORMATION JOURNAL (2008)
Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation
Juris J. Liepnieks et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2007)
Liver transplantation for familial amyloidotic polyneuropathy (FAP):: A single-center experience over 16 years
S. Yamamoto et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: Outcomes of living donor liver transplantations
Y Takei et al.
INTERNAL MEDICINE (2005)
Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type
BO Olofsson et al.
TRANSPLANTATION (2002)
Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin
M Yazaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation
D Adams et al.
BRAIN (2000)
Share Paper
